- Home
- LOT vs NEO Comparison
LOT vs NEO Comparison
Compare LOT & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOT
- NEO
- Stock Information
- Founded
- LOT 1948
- NEO 2001
- Country
- LOT China
- NEO United States
- Employees
- LOT N/A
- NEO N/A
- Industry
- LOT
- NEO Precision Instruments
- Sector
- LOT
- NEO Health Care
- Exchange
- LOT NYSE
- NEO Nasdaq
- Market Cap
- LOT 956.3M
- NEO 963.9M
- IPO Year
- LOT N/A
- NEO 1999
- Fundamental
- Price
- LOT $2.33
- NEO $6.27
- Analyst Decision
- LOT
- NEO Buy
- Analyst Count
- LOT 0
- NEO 9
- Target Price
- LOT N/A
- NEO $13.31
- AVG Volume (30 Days)
- LOT 86.8K
- NEO 1.6M
- Earning Date
- LOT 08-27-2025
- NEO 07-29-2025
- Dividend Yield
- LOT N/A
- NEO N/A
- EPS Growth
- LOT N/A
- NEO N/A
- EPS
- LOT N/A
- NEO N/A
- Revenue
- LOT $844,090,000.00
- NEO $672,361,000.00
- Revenue This Year
- LOT $40.53
- NEO $13.97
- Revenue Next Year
- LOT $87.99
- NEO $11.36
- P/E Ratio
- LOT N/A
- NEO N/A
- Revenue Growth
- LOT 1.33
- NEO 10.10
- 52 Week Low
- LOT $1.06
- NEO $6.08
- 52 Week High
- LOT $7.42
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- LOT 59.44
- NEO 33.60
- Support Level
- LOT $2.06
- NEO $7.20
- Resistance Level
- LOT $2.39
- NEO $7.82
- Average True Range (ATR)
- LOT 0.13
- NEO 0.32
- MACD
- LOT 0.01
- NEO -0.06
- Stochastic Oscillator
- LOT 87.88
- NEO 0.41
About LOT LOTUS TECHNOLOGY INC
Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.